ArticleTrials2024

A phase II trial examining the safety and preliminary efficacy of repetitive transcranial magnetic stimulation (rTMS) for people living with multiple sclerosis.

Natasha Stevens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.